Platform Technology

Three Components of MangoGen’s Patented Platform Technology

1.  Insertion of human gene(s) in to a baculovirus.
2.  Protection from serum inactivation by encapsulation
3.  Coating onto a suitable matrix, or formulated into a cream/gel

Schematic illustrating MangoGen’s Technology applied to a cardiac stent

MangoGen is developing the following:

1. New generation of gene-delivering cardiac stents
2. Gene-delivering cream/gel to accelerate open wound healing (e.g. diabetic foot ulcers, surgery, wound repair)
3. Gene-delivering sutures to prevent scar tissue formation

 

2017